Podcasts about frcs

The Journal of Arthroplasty: The Cut brings you another very special episode based on Knee Society Proceedings that highlight important research about knee arthroplasty. In this episode of The Cut, our host Kim K. Tucker, MD speaks with our guest Simon W. Young, MD, FRCS about the John N. Insall award-winning study on Functional Versus Mechanical Aligment in Total Knee Arthroplasty.  Mechanical alignment (MA) in total knee arthroplasty is regarded as a gold standard; however, some patients report dissatisfaction postsurgery. Functional alignment (FA) is a potential alternative, integrating kinematic alignment (KA) principles with preresection bone balancing within defined boundaries. In this prospective, randomized controlled trial in robotic-assisted total knee arthroplasty, interesting results were uncovered.  Tune in to the full recording to find out what was discovered. And thanks for listening to The Journal of Arthroplasty: The Cut! In This Episode:Kim Tucker, MDSimon W. Young, MD, FRCS  The post Functional Versus Mechanical Alignment in Total Knee Arthroplasty first appeared on AAHKS.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027.Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027.Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027.Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027.Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027.Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027.Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics.Disclosure information is available at the beginning of the video presentation.

In this episode, Jamie Wilson, MD, FRCS, MSc interviews Christopher Ahuja, MD, PhD, FRCSC, FAANS and Michael Fehlings, MD, PhD, FRCSC, about the challenges of sustaining a research career alongside a demanding spine surgery practice. They discuss how long timelines for scientific discovery, frequent setbacks in research, and competing clinical responsibilities can contribute to burnout. The conversation highlights strategies for maintaining motivation, including focusing on incremental progress, setting meaningful milestones, and protecting time for work, family, and personal well-being.

This is an episode unlike any we have shared before. The meaning of mentorship is spoken about on another level with Dr. Myron Tucker and Dr. Bryan Bell. Although they are linked in the traditional mentor/mentee way they also have bonded on the influence Dr. Bell's father has had on both of them. We encourage you to give this episode a listen, especially to the end where Dr. Bell shares a touching poem written about his first mentor, his father.

In this episode, we break down a classic FRCS General Surgery viva scenario involving a patient who becomes septic after elective bowel surgery following an ileocolic resection.We discuss how to approach a deteriorating postoperative patient with wound discharge, suspected anastomotic leak, enterocutaneous fistula, intra-abdominal contamination, and the urgent decision of whether the patient needs a return to theatre.Perfect for FRCS candidates, core surgical trainees, registrars, and anyone interested in emergency general surgery.If you're preparing for the FRCS exam, this channel covers real-world scenarios, viva strategy, and consultant-level thinking.

The Journal of Arthroplasty: The Cut brings you another very special episode based on Knee Society Proceedings that highlight important research about knee arthroplasty. In this episode of The Cut, our hosts Kim K. Tucker, MD and Nathanael D. Heckmann, MD welcomed guests Jeremy M. Gililland, MD, George Grammatopoulos, MD, FRCS and Elizabeth G. Lieberman, MD to review and discuss studies that go beyond the implant and into the system. This recording is looking at outcomes that vary a great deal depending on where and what kind of care patients receive. Our hosts and guests took a deep dive into the intersection between hospital systems, implant selection and the surgical approach with respect to hip fracture management. Together these things raise questions about where patients are treated, how they choose their implant and if new surgical trends deliver on results. Join us for this enlightening recording that we think you’ll find useful. Enjoy and thanks for listening to The Journal of Arthroplasty: The Cut! In This Episode: Jeremy M. Gililland, MD George Grammatopoulos, MD, FRCS Nathanael D. Heckmann, MD Elizabeth G. Lieberman, MD Kim K. Tucker, MD The post Arthroplasty and Hip Fractures first appeared on AAHKS.

The Journal of Arthroplasty: The Cut brings you another very special episode based on Knee Society Proceedings that highlight important research about knee arthroplasty. In this episode of The Cut, our hosts Kim K. Tucker, MD and Nathanael D. Heckmann, MD welcomed guests Jeremy M. Gililland, MD, George Grammatopoulos, MD, FRCS and Elizabeth G. Lieberman, MD to review and discuss studies that go beyond the implant and into the system. This recording is looking at outcomes that vary a great deal depending on where and what kind of care patients receive. Our hosts and guests took a deep dive into the intersection between hospital systems, implant selection and the surgical approach with respect to hip fracture management. Together these things raise questions about where patients are treated, how they choose their implant and if new surgical trends deliver on results. Join us for this enlightening recording that we think you’ll find useful. Enjoy and thanks for listening to The Journal of Arthroplasty: The Cut! In This Episode: Jeremy M. Gililland, MD George Grammatopoulos, MD, FRCS Nathanael D. Heckmann, MD Elizabeth G. Lieberman, MD Kim K. Tucker, MD The post Arthroplasty and Hip Fractures first appeared on AAHKS.

For many women, a history of breast cancer has meant an automatic “no” when it comes to menopausal hormone therapy. But is the story really that simple? In this video, we explore a more nuanced and evolving conversation—one grounded in decades of research, including the work of Avrum Z. Bluming, MD, and other leading experts who have closely examined the data on hormone therapy after breast cancer. Across multiple studies and reviews spanning over 40 years, the evidence paints a more complex picture. While certain risks—such as thromboembolism with oral formulations—are well documented, the long-held belief that hormone therapy universally increases breast cancer recurrence or mortality is increasingly being questioned. In fact, most studies have not shown an increase in breast cancer–related death, and only one trial demonstrated a limited increase in local (not distant) recurrence. At the same time, menopausal hormone therapy remains the most effective treatment for symptoms that deeply affect quality of life—while also offering potential benefits for cardiovascular health, bone strength, cognitive function, and longevity. So where does this leave us? This video is not about giving a one-size-fits-all answer. It's about encouraging thoughtful, informed decision-making. It's about moving beyond fear-based assumptions and toward individualized care—where risks and benefits are carefully weighed, and where women feel empowered to ask questions, seek multiple perspectives, and have meaningful conversations with their physicians. Because the most important takeaway is this: you deserve to be fully informed. Resources: Hormone Replacement Therapy After Breast Cancer: It Is Time Avrum Z. Bluming, MD LINK - https://bit.ly/4st0uji Menopausal Hormone Therapy for Breast Cancer Patients: What Is the Current Evidence? Sarah Glynne, MBBS, MSc, MRCP, MRCGP; James Simon, MD; Anthony Branson, FRCP; Stephen Payne, FRCS; Louise Newson, MBChB; Isaac Manyonda, PhD; Susan Cleator, PhD; Michael Douek, MD; Sasha Usiskin, MRCP; Jeffrey S. Tobias, MD; Jayant S. Vaidya, PhD LINK - https://bit.ly/41leKyt

Emergency Femoral Hernia is a classic FRCS General Surgery exam scenario and a true life-saving emergency operation.In this episode of the Scrubbing In FRCS Podcast, we walk through the complete step-by-step approach to an emergency femoral hernia, exactly how you should present it in the exam and manage it in real life.We cover the full FRCS viva framework, including anatomy, resuscitation, CT decision making, consent, operative approach, bowel resection, mesh vs no mesh, and post-operative care.This is essential revision for:• FRCS General Surgery candidates• Core Surgical Trainees (CST)• ST3+ surgical trainees• MRCS candidates• Junior doctors preparing for surgical exams⸻

This episode features Kerstin Sandelin, MD, PhD, FACS(Hon), FRCS, a breast surgeon from Stockholm, Sweden, who gave the Distinguished Lecture of the International Society of Surgery during the American College of Surgeons (ACS) Clinical Congress in Chicago. In her lecture, Dr. Sandelin addressed the gaps in breast cancer care throughout the world and offered information about how low- and middle-income countries will benefit from global standardization. Talk about the podcast on social media using the hashtag #HouseofSurgery

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WBF865. EBAC/CME credit will be available until December 30, 2026.New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WBF865. EBAC/CME credit will be available until December 30, 2026.New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WBF865. EBAC/CME credit will be available until December 30, 2026.New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WBF865. EBAC/CME credit will be available until December 30, 2026.New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WBF865. EBAC/CME credit will be available until December 30, 2026.New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WBF865. EBAC/CME credit will be available until December 30, 2026.New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This episode features C. William Schwab, MD, FACS, FRCS, a retired US Navy Commander from Philadelphia, who is among the growing number of trauma surgeons urging national trauma readiness. During the Edward D. Churchill Lecture at the American College of Surgeons (ACS) Clinical Congress in Chicago, Dr. Schwab said that the US healthcare system's ability to respond to mass casualty events, including warfare-related injuries, is predicated on the preparedness of every surgeon and hospital system.   Talk about the podcast on social media using the hashtag #HouseofSurgery.  

Welcome back to Scrubbing In — it's been a long time, but we're back!In this episode, we break down one of the most important and high-stakes emergencies in general surgery: necrotizing fasciitis. We walk through:

Welcome to GT: The Podcast! In this episode, Mohamed M. Khodeiry, MD, MSc, recaps his article, “Glaucoma Intrascleral Tube Surgery,” written with James Richardson-May, MD, and Ahmed Elbably, MSc, FRCS, and featured in the July/August issue of Glaucoma Today. A surgical modification called glaucoma intrascleral tube surgery (GITS) may help address some postoperative complications associated with subconjunctival stent implantation. Dr. Khodeiry discusses the development of GITS, specifics of the surgical technique, early outcomes, and future directions.

Send us a textSeason 3 Episode 12 (Part II)Professor Chris Booth MBBS, FRCS – Consultant UrologistIn this second episode we are once again joined by Professor Chris Booth, MBBS, FRCS — a leading Consultant Urologist and one of the UK's most respected voices in men's health. Professor Booth is the founder of CHAPS, a dedicated men's health charity established to improve awareness, early diagnosis, and access to better health services for men across the country.With a distinguished career in urology, Professor Booth has become a national expert in urological service redesign, championing modern, integrated care pathways that deliver faster, more effective, and more affordable treatment. His work is especially transformative in rural communities, where access to specialist services can be limited, and where his innovative approach has helped bridge the gap between primary and specialist care.Driven by a passion for prevention, early detection, and patient-focused care, Professor Booth continues to lead the conversation about how we can improve men's health outcomes and reduce avoidable deaths from diseases such as prostate cancer.We're thrilled to have him with us today to share his insights, experience, and vision for the future of men's health.https://chaps-uk.org#HeartTransplant#eatingdisorder#RareCondition#HealthJourney#LifeChangingDiagnosis#MentalHealth#Vulnerability#SelfCompassion#PostTraumaticGrowth#MedicalMiracle#BBCSports#Inspiration#Cardiology#Surgery#Podcast#Healthcare#HeartHealth#MedicalBreakthrough#EmotionalJourney#SupportSystem#HealthcareHeroes#PatientStories#CardiologyCare#MedicalJourney#LifeLessons#MentalWellness#HealthAwareness#InspirationalTalk#LivingWithIllness#RareDiseaseAwareness#SharingIsCaring#MedicalSupport#BBCReporter#HeartDisease#PodcastInterview#HealthTalk#Empowerment#Wellbeing#HealthPodcast#prostatecancer#Aid's#prostateCheck out our website at www.whostomanddick.comCheck out our website at www.whostomanddick.com

Uday Devgan, MD, FACS, FRCS, speaks with Christopher E. Starr, MD, FACS, and Brian Shafer, MD, in two short segments drawn from CRST's October cover focus, "Refractive Cataract Roundtables." Dr. Starr reviews a practical approach to preoperative ocular surface optimization—key exam steps, stop-rules before biometry, and simple readiness markers. Dr. Shafer outlines his IOL decision framework, balancing spectacle independence and image quality, who is not a candidate for diffractive optics, and options for residual refractive error. Related perspectives appear in the October issue of CRST.

Send us a textSeason 3 Episode 11Professor Chris Booth MBBS, FRCS – Consultant UrologistIn today's episode, we're joined by Professor Chris Booth, MBBS, FRCS — a leading Consultant Urologist and one of the UK's most respected voices in men's health. Professor Booth is the founder of CHAPS, a dedicated men's health charity established to improve awareness, early diagnosis, and access to better health services for men across the country.With a distinguished career in urology, Professor Booth has become a national expert in urological service redesign, championing modern, integrated care pathways that deliver faster, more effective, and more affordable treatment. His work is especially transformative in rural communities, where access to specialist services can be limited, and where his innovative approach has helped bridge the gap between primary and specialist care.Driven by a passion for prevention, early detection, and patient-focused care, Professor Booth continues to lead the conversation about how we can improve men's health outcomes and reduce avoidable deaths from diseases such as prostate cancer.We're thrilled to have him with us today to share his insights, experience, and vision for the future of men's health.https://chaps-uk.org#HeartTransplant#eatingdisorder#RareCondition#HealthJourney#LifeChangingDiagnosis#MentalHealth#Vulnerability#SelfCompassion#PostTraumaticGrowth#MedicalMiracle#BBCSports#Inspiration#Cardiology#Surgery#Podcast#Healthcare#HeartHealth#MedicalBreakthrough#EmotionalJourney#SupportSystem#HealthcareHeroes#PatientStories#CardiologyCare#MedicalJourney#LifeLessons#MentalWellness#HealthAwareness#InspirationalTalk#LivingWithIllness#RareDiseaseAwareness#SharingIsCaring#MedicalSupport#BBCReporter#HeartDisease#PodcastInterview#HealthTalk#Empowerment#Wellbeing#HealthPodcast#Harryhill#Aid's#MynaraCheck out our website at www.whostomanddick.comCheck out our website at www.whostomanddick.comCheck out our website at www.whostomanddick.com

Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC

Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC

Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC

Fred Saad, MD, FRCS - From Platform to Practice: Insights From ESMO 2025 on the Latest Data Guiding Contemporary Care in mHSPC and nmCRPC

Device Nation sits down for an inspiring conversation with THE world's preeminent authority on bone infection, Professor Martin McNally!We talk Osteomyelitis, FRI, Girdlestone Society, antibiotic stewardship, Solario, ABX delivery carriers,rowing and a product worthy of consideration for your bag, your OR….CERAMENT G!In this episode you will learn:Where we are on the DAIRWhere the word “Girdlestone” came from How antibiotic-impregnated cement can create resistanceThe concept of "Antibiotic Stewardship”Best practices to prevent intra-op and field infectionsThe genesis of CERAMENT GGuinness Stout….to chill or not to chill?……..and so much more!!Martin McNally is Honorary Consultant in Limb Reconstruction at the Oxford Bone Infection Unit in the Nuffield Orthopaedic Centre, Oxford University Hospitals and King James IV Professor at the Royal College of Surgeons of Edinburgh.He has a particular interest in osteomyelitis, infected fractures and non-unions. He has published over 200 peer-reviewed papers, reviews and book chapters. His current research and clinical studies focus on diagnosis and treatment options together with assessment of outcomes and quality of life for infection patients. He has been a champion of multi-disciplinary working in bone infection and was lead surgeon in the Oxford Unit for 20 years. Validated protocols and treatment methods designed in Oxford are now widely used around the worldHe is Past-President of the European Bone and Joint Infection Society (EBJIS) and the Girdlestone Orthopaedic Society. He is a member of the EFORT Scientific and Education Committees and Co-chair of the International Fracture-related Infection (FRI) Group.Lastly, big announcement for those attending AAHKS this year…can't wait to see you in Grapevine!Room: Dallas 6Friday, October 24th6:30-8:30 AMOVIVA Trial: https://pubmed.ncbi.nlm.nih.gov/30699315/CERAMENT G: https://www.bonesupport.com/en-eu/products/cerament-g/JBJS Paper: https://pubmed.ncbi.nlm.nih.gov/36047024/Professor McNally Research Works: https://www.researchgate.net/profile/Martin-Mcnally-2This is an orthopedic expert discussion on the use of BONESUPPORT's product CERAMENT(R) G. Some of the uses discussed here may not be approved or cleared by FDA. The expert is independent and the content is not in any way influenced by BONESUPPORT. For complete product information, including indications, contraindications, warnings, precautions and potential adverse events, see package insert.Support the show

AUA2025: Key Takeaways: Endourology/Stones Highlights Presenters: Davis Viprakasit, MD & Stephen Nakada MD, FACS, FRCS

Upgunned variants of NSCs and FRCs could help Navy readiness.

Camidge and O'Riordan discussed how O'Riordan's breast surgery career intersected with her personal experience with breast cancer. She shared the stories behind her initial diagnosis, subsequent treatments, and disease recurrences. She also emphasized the importance of open communication with patients about aspects of cancer survivorship, such as emotional wellbeing and sexual health. O'Riordan also talked about her career transition from the surgery field to patient advocacy, as well as her future plans for writing, speaking, and offering support to the breast cancer community. 

Before we dive in, my new cookbook Healthy High Protein is out now…and it's a Sunday Times bestseller! I'm super proud of this book and hope you love it too. You can get your copy here.We know it can be hard to keep up with hours of podcast content every week. In fact, over the past couple of months alone, we've shared more than 48 hours of conversations!So in today's episode, we've distilled some of the key takeaways to save you time and go straight to the expert advice they've so generously shared.If you're a regular listener, you'll recognise some familiar voices. You can find the full episodes on The Doctor's Kitchen website:#281 How Phone Fasting and Nature Can Build Dopamine and Support Your Brain with TJ Power#280 The Cholesterol Numbers We Should All Know with Professor Kausik Ray#285 What a Gut Healthy Day Looks Like with Dr James Kinross PhD, FRCS#286 Why Looking at Your Poo Is Key to Understanding Your Health with Dr Emily Leeming#267 Think Clearer and Stay Sharp with These Brain Health Strategies from Neurophysiologist Dr Louisa Nicola#282 How to Move Better with Exercise Strategies for Longevity, Fat Loss, and Sharper Brains with Kiran Chopra#251 Women's Health and Problem Periods with Dr Anita Mitra#279 How to Make Habits Stick with Dr Rangan ChatterjeeWe want to hear from you!

Setkání s jednou z nejvýraznějších osobností transplantologie, Prof. MUDr. Jiří Froňkem, Ph.D. FRCS, přednostou Kliniky transplantační chirurgie IKEM. Pozornost na sebe upoutal unikátními transplantacemi. Například přenosem dělohy. Jako první v ČR transplantoval játra z žijícího dárce na žijícího příjemce. Do studia s ním přišla manželka Ivana Froněk Malá, choreografka, spoluzakladatelka a ředitelka Tanečního studia Emotions.

We know that gut health plays a crucial role in everything from digestion to immunity, weight management, and even mental well-being. But what does looking after your gut actually look like in practice?In this episode, I'm again joined by Dr James Kinross a senior lecturer in colorectal surgery and consultant surgeon at Imperial College London, he's a researcher, and author of Dark Matter, to explore the science behind our gut microbiome—and how we can take actionable steps to support it every single day.

Dr. Javad Parvizi, MD, FRCS, the newly appointed Professor of Orthopedic Surgery at Acibadem University in Istanbul. With a career spanning over 25 years, Dr. Parvizi has performed more than 10,000 surgical procedures, including over 1,000 hip joint preservation surgeries. He is globally renowned for his pioneering work in managing periprosthetic joint infection and venous thromboembolism. Before joining Acibadem University, Dr. Parvizi was the Director and Vice Chair of Research at the Rothman Institute. He has authored over 1,000 peer-reviewed articles, penned 18 textbooks, and received over 100 awards from prestigious medical organizations. His research is well-funded by top institutions such as the National Institutes of Health and the Department of Defense. Dr. Parvizi's extensive training includes a medical degree from the UK, cardiothoracic surgical training in Great Britain, and a residency in orthopedic surgery at the Mayo Clinic. He completed a fellowship in Switzerland under Professor Reinhold Ganz, focusing on hip disorders in young adults. In 2003, he joined the Rothman Orthopedic Institute and served as the James Edward Professor of Orthopedic Surgery at Sidney Kimmel School of Medicine until 2023. Dr. Parvizi has held numerous leadership roles, including president of the Musculoskeletal Infection Society and the Eastern Orthopedic Association, and he is currently the President of the American Association of Hip and Knee Surgeons (AAHKS). He co-founded the International Consensus Group, which produced a comprehensive resource on orthopedic infections. In addition to his medical achievements, Dr. Parvizi is the founder and CEO of Parvizi Surgical Innovation (PSI) LLC, an incubator for developing groundbreaking healthcare products. He has trained over 2,000 research and clinical fellows and residents, and his dedication to education and global knowledge sharing has earned him honorary memberships in numerous organizations. Dr. Parvizi continues his commitment to excellence at Acibadem University, where he co-founded the International Joint Center (IJC) at Acibadem Hospital.  Tune in to hear Dr. Parvizi discuss his remarkable career, innovations in orthopedic surgery, and his vision for the future.  

This spectacular keynote address was given by Dr. David Knott at the “Mattox” Trauma Conference in 2023. Mattox Vegas TCCACS: https://www.trauma-criticalcare.com/ War Doctor: https://www.amazon.com/War-Doctor-Surgery-Front-Line/dp/1419744240/ref=asc_df_1419744240/?tag=hyprod-20&linkCode=df0&hvadid=508953752346&hvpos=&hvnetw=g&hvrand=15602939439351749599&hvpone=&hvptwo=&hvqmt=&hvdev=c&hvdvcmdl=&hvlocint=&hvlocphy=9009673&hvtargid=pla-906115140419&psc=1 The David Nott Foundation: https://davidnottfoundation.com/ Dr. Nott on BTK July 1, 2020: https://behindtheknife.org/podcast/war-doctor-david-nott-on-surgery-in-war-zones/ David gained his medical degree from Manchester University and in 1992 gained his FRCS from the Royal College of Surgeons of England to become a Consultant Surgeon. He is a Consultant Surgeon at St Mary's Hospital where he specialises in vascular and trauma surgery and also performs cancer surgery at the Royal Marsden Hospital. David is an authority in laparoscopic surgery and was the first surgeon to combine laparoscopic and vascular surgery. For the past 30 years David has taken unpaid leave to work for the aid agencies Médecins Sans Frontières, the International Committee of the Red Cross and Syria Relief. He has provided surgical treatment to patients in conflict and catastrophe zones in Bosnia, Afghanistan, Sierra Leone, Liberia, Ivory Coast, Chad, Darfur, Yemen, the Democratic Republic of Congo, Haiti, Iraq, Pakistan, Libya, Syria, Central African Republic, Palestine, Nepal and Ukraine As well as treating patients affected by conflict and catastrophe and raising hundreds of thousands of pounds for charitable causes, David teaches advanced surgical skills to local medics and surgeons when he is abroad. In Britain, he set up and led the teaching of the Surgical Training for the Austere Environment (STAE) course at the Royal College of Surgeons. In 2015 David established the David Nott Foundation with his wife Elly. The Foundation supports surgeons in developing their operating skills for war zones and austere environments and has now trained over 900 doctors through their bespoke Hostile Environment Surgical Training (HEST) course. In 2019, Picador published David's bestselling memoir, War Doctor. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episode list here: https://behindtheknife.org/listen/